HUANG Linglong, WANG GuANDong, ZHANG Jieping, et al. Systematic Review of Clinical Efficacy of Jisheng Shenqi Pills for Diabetic Nephropathy. [J]. 20(5):586-592(2020)
HUANG Linglong, WANG GuANDong, ZHANG Jieping, et al. Systematic Review of Clinical Efficacy of Jisheng Shenqi Pills for Diabetic Nephropathy. [J]. 20(5):586-592(2020) DOI: 10.14009/j.issn.1672-2124.2020.05.020.
Systematic Review of Clinical Efficacy of Jisheng Shenqi Pills for Diabetic Nephropathy
摘要
目的:系统评价济生肾气丸用于糖尿病肾病的治疗效果
为临床实践提供参考。方法:计算机检索the Cochrane Library、EMBase、PubMed、Web of Science、Allied and Complementary Medicine、中国知网、维普数据库、中国生物医学文献数据库及万方数据库建库至2019年7月16日收录的济生肾气丸用于糖尿病肾病治疗的随机对照试验文献(对照组患者采用常规治疗措施如控制饮食、保证良好规律的作息以及预防感染等
OBJECTIVE: To systematically evaluate the clinical effects of Jisheng Shenqi pills for diabetic nephropathy
so as to provide reference for further clinical practice. METHODS: The Cochrane Library
EMBase
PubMed
Web of Science
Allied and Complementary Medicine
CNKI
VIP database
CBM and Wanfang database were retrieved to collect the randomized controlled trial of Jisheng Shenqi pills for diabetic nephropathy( the control group was treated with conventional treatment measures such as diet control
regular schedule and rest assurance
and infection prevention
while the study group received Jisheng Shenqi formula recipe or Jisheng Shenqi pills combined with other traditional Chinese medicine decoction and Chinese patent medicine). The retrieval time was from the establishment of the database to Jul. 16 th
2019. The cochrane reviews handbook version 5. 1. 0 was adopted for literature quality evaluation
and the Rev Man 5. 3 software was used for Meta-analysis. RESULTS: Totally 15 literature were collected.Meta analysis results showed that the effective rate of the observation group was significantly higher than that of the control group( RR = 1. 32
95% CI = 1. 23-1. 42
P <0. 01)
and the 24 h urine protein quantification was significantly lower than that of the control group( MD =-0. 16
95%CI =-0. 21—-0. 11
P<0. 01)
2 h postprandial blood glucose was significantly better than that of the control group( MD =-1. 29
95% CI =-1. 62—-0. 96
P < 0. 01)
the content of glycated hemoglobin was significantly lower than that of the control group( MD =-1. 32
95% CI =-2. 08—-0. 57
P <0. 01)
the differences were statistically significant. CONCLUSIONS: The clinical effects of Jisheng Shenqi pills for diabetic nephropathy is significant. Yet the methodological quality of the literature included in this study is relatively low
and rigorous high-quality clinical randomized controlled trials still need to be designed in the future.